PSI (trifluoroacetate salt)
(Synonyms: Proteasome Inhibitor I, Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde, Z-Ile-Glu(OtBu)-Ala-Leu-CHO) 目录号 : GC48406
A proteasome inhibitor
Sample solution is provided at 25 µL, 10mM.
PSI is a synthetic peptide proteasome inhibitor.1,2,3 It inhibits the acidic and neutral chymotrypsin-like activities of the 20S proteasome (IC50s = 0.25 and 6.5 µM, respectively).3 PSI is cytotoxic to HL-60, KG-1a, RWLeu-4, AR230, and K562 human leukemia cells (IC50s = 4.9, 17.5, 7.8, 7.3, and 10 nM, respectively).4 It selectively induces apoptosis in subconfluent bovine aortic endothelial cells (BAECs) and human umbilical vein endothelial cells (HUVECs; EC50s = 24 and 7 nM, respectively) over confluent BAECs and HUVECs (EC50s = 8,150 and 7,830 nM, respectively).5 PSI induces accumulation of ubiquitin-protein conjugates in HT4 mouse neuronal cells.6
1.Collins, G.A., and Goldberg, A.L.The logic of the 26S proteasomeCell169(5)792-806(2017) 2.Orlowski, M., and Wilk, S.Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complexArch. Biochem. Biophys.383(1)1-16(2000) 3.Figueiredo-Pereira, M.E., Chen, W.-E., Yuan, H.-M., et al.A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pHArch. Biochem. Biophys.317(1)69-78(1995) 4.Soligo, D., Servida, F., Delia, D., et al.The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSIBr. J. Haematol.113(1)126-135(2001) 5.Drexler, H.C., Risau, W., and Konerding, M.A.Inhibition of proteasome function induces programmed cell death in proliferating endothelial cellsFASEB J.14(1)65-77(2000) 6.Figueiredo-Pereira, M.E., Berg, K.A., and Wilk, S.A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cellJ. Neurochem.63(4)1578-1581(1994)
Cas No. | SDF | ||
别名 | Proteasome Inhibitor I, Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde, Z-Ile-Glu(OtBu)-Ala-Leu-CHO | ||
Canonical SMILES | O=C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(OC(C)(C)C)=O)C(N[C@@H](C)C(N[C@H](C=O)CC(C)C)=O)=O)=O)OCC1=CC=CC=C1.OC(C(F)(F)F)=O | ||
分子式 | C32H50N4O8•XCF3COOH | 分子量 | 618.8 |
溶解度 | Formic Acid: 1 mg/ml | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.616 mL | 8.0802 mL | 16.1603 mL |
5 mM | 0.3232 mL | 1.616 mL | 3.2321 mL |
10 mM | 0.1616 mL | 0.808 mL | 1.616 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet